Back
Ranpak Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
37
PACK
Ranpak Holdings
Last Price:
$6.70
Seasonality Move:
-6.91%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$106.83
Seasonality Move:
8.04%
Sell
37
Ranpak Holdings (PACK)
is a Sell
Is Ranpak Holdings a Buy, Sell or Hold?
-
The current Ranpak Holdings [PACK] share price is $6.69. The Score for PACK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
PACK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PACK Stock Price Chart
What is Ranpak Holdings's stock price today?
-
The Ranpak Holdings share price today is $6.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACK is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
PACK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 43.13 | Sell |
Chaikin Money Flow: | -578704 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.55 - 7.83) | Sell |
Bollinger Bands (100): | (6.18 - 7.6) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.25 | Sell |
Relative Strength Index (14 RSI): | 41.97 | Sell |
Chaikin Money Flow: | 469170 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.93 - 115.87) | Sell |
Bollinger Bands (100): | (111.92 - 127.28) | Sell |
PACK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.07 | Sell |
20-day SMA: | 7.37 | Sell |
50-day SMA: | 7.01 | Sell |
200-day SMA: | 6.78 | Sell |
8-day EMA: | 7.02 | Sell |
20-day EMA: | 7.14 | Sell |
50-day EMA: | 7.08 | Sell |
200-day EMA: | 6.74 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 106.35 | Buy |
20-day SMA: | 109.97 | Sell |
50-day SMA: | 116.57 | Sell |
200-day SMA: | 127.54 | Sell |
8-day EMA: | 106.76 | Buy |
20-day EMA: | 109.7 | Sell |
50-day EMA: | 114.67 | Sell |
200-day EMA: | 122.08 | Sell |
Ranpak Holdings Earnings Growth & PACK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.09 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.
Ranpak Holdings Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |